Barry W. Miller - Concepedia

Author

Barry W. Miller

Thomas Jefferson National Accelerator Facility

Also Known As

B Miller, B. MILLER, B. Miller, B. W. MILLER, B. W. Miller, Barry Miller, Barry W. Miller, Jonah Long, Miller, B.

Publications

540

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson National Accelerator Facility United States Food and Drug Administration Istituto Nazionale di Fisica Nucleare, Sezione di Genova National Cancer Institute University of Glasgow

About

Barry W. Miller is an author at Thomas Jefferson National Accelerator Facility specializing in biochemistry, natural sciences, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	4	4	85
2	Biochemistry	4	4	78
3	Engineering	3	3	49
4	Medicine	3	3	77
5	Health Sciences	2	2	61

Barry W. Miller

Publications

329

Citations

H-Index

Page 1

	Year	Citations
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia Steven T. Bird, Fang Tian, Natasha Flowers, JAMA Oncology	2019	64
Neutrophil defect associated with malignant infantile osteopetrosis. Claire Beard, L. Lyndon Key, Peter E. Newburger, PubMed	1986	55
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia Hyon-Zu Lee, Barry W. Miller, Virginia E. Kwitkowski, Clinical Cancer Research ImmunologyFda ApprovalPharmacotherapyImmunotherapyDrug Resistance	2014	41
A 1,5-diazabicyclo[3.3.3]undecane derivative with almost planar bridgehead nitrogens Roger W. Alder, Nigel C. Goode, Trevor J. King, Journal of the Chemical Society Chemical Communications HeterocyclicBiochemistryPhysicochemical AnalysisNatural SciencesSpectra-structure Correlation	1976	39
The CLAS12 high threshold Cherenkov counter Y. G. Sharabian, Volker Burkert, A. S. Biselli, Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Nuclear PhysicsPhysicsNatural SciencesParticle PhysicsDetector Physic	2020	23
FDA analysis of pembrolizumab trials in multiple myeloma: Immune related adverse events (irAEs) and response. Aviva C. Krauss, Flora Mulkey, Yuan-Li Shen, Journal of Clinical Oncology Checkpoint InhibitionImmunologyPharmacotherapyImmunotherapyHematological Malignancy	2018	20
The CLAS12 Forward Time-of-Flight system D. S. Carman, L. Clark, R. De Vita, Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment EngineeringAerospace EngineeringAircraft NavigationSystems EngineeringAerospace System	2020	20
18-Substituted steroids—9[1]. Studies on the stability of aldosterone in dilute alkali David N. Kirk, Barry W. Miller Journal of Steroid Biochemistry Aldo-keto ReductaseBiochemistryMedicinePhysiology18-Substituted Steroids—9	1982	16
The CLAS12 Central Time-of-Flight system D. S. Carman, G. Asryan, V. Baturin, Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment EngineeringAerospace EngineeringAircraft NavigationSystems EngineeringClock Synchronization	2020	16
Boron-nitrogen compounds. Part 117. Pyrazaboles of the type RR'B(.mu.-pz)2BRR' and related studies Mithun Das, Allison Lynne DeGraffenreid, Korie Edwards, Inorganic Chemistry Inorganic ChemistryBoron NitrideRelated StudiesEngineeringBiochemistry	1988	13

Page 1